Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00734968 · ClinicalTrials.gov registry record · Phase 4
Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
A Phase 4 study of Stress Incontinence, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT00734968: Completed Phase 4 study of Stress Incontinence, sponsored by University of Missouri-Columbia.
NCT00734968 is a Phase 4 study of Stress Incontinence that has completed, run by University of Missouri-Columbia. The registered enrollment target is 161 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00734968, a Phase 4 study of Stress Incontinence, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will determine whether post-operative prophylaxis with macrobid will decrease the incidence of postoperative urinary tract infection in women receiving sub-urethral slings for the treatment of urinary incontinence.
Primary Outcome
The overall rate of UTI following the placement of sub-urethral sling for the treatment of stress urinary incontinence in our study was 24.8% (n = 37)
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Nitrofurantoin
Study Locations (1)
Texas
- Scott and White Hosptial, Texas A&M University - Temple
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
What the finished NCT00734968 record still lists
NCT00734968 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Stress Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00734968 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00734968 about?
NCT00734968 is a clinical study titled "Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence". This project will determine whether post-operative prophylaxis with macrobid will decrease the incidence of postoperative urinary tract infection in women receiving sub-urethral slings for the treatment of urinary incontinence.
What is the current status of trial NCT00734968?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 161 participants. The study started on 2008-05. Estimated completion is 2010-05.
What conditions does trial NCT00734968 study?
This clinical trial studies the following conditions: Stress Incontinence.
What interventions are being tested in trial NCT00734968?
The interventions under investigation include: Placebo (OTHER), Nitrofurantoin (DRUG).
Who is sponsoring clinical trial NCT00734968?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00734968 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00734968's enrollment target sits among peer trials
161 506th of 2000 higher than 1,494 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia